Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Biomed Environ Sci ; 35(7): 613-621, 2022 Jul 20.
Article de Anglais | MEDLINE | ID: mdl-35945176

RÉSUMÉ

Objective: To analyze the prevalence of dry and wet age-related macular degeneration (AMD) in patients with diabetes, hypertension and hyperlipidemia, and to analyze the risk factors for AMD. Methods: A population-based cross-sectional epidemiologic study was conducted involving 14,440 individuals. We assessed the prevalence of dry and wet AMD in diabetic and non-diabetic subjects and analyzed the risk factors for AMD. Results: The prevalence of wet AMD in diabetic and non-diabetic patients was 0.3% and 0.5%, respectively, and the prevalence of dry AMD was 17% and 16.4%, respectively. The prevalence of wet AMD in healthy, hypertensive, hyperlipidemic, and hypertensive/hyperlipidemic populations was 0.5%, 0.3%, 0.2%, and 0.7%, respectively. The prevalence of dry AMD in healthy, hypertensive, hyperlipidemic, and hypertensive/hyperlipidemic populations was 16.6%, 16.2%, 15.2%, and 17.2%, respectively. Age, sex, body mass index, and use of hypoglycemic drugs or lowering blood pressure drugs were corrected in the risk factor analysis of AMD. Diabetes, diabetes/hypertension, diabetes/hyperlipidemia, and diabetes/hypertension/hyperlipidemia were analyzed. None of the factors analyzed in the current study increased the risk for the onset of AMD. Conclusion: There was no significant difference in the prevalence of wet and dry AMD among diabetic and non-diabetic subjects. Similarly, there was no significant difference in the prevalence of wet and dry AMD among subjects with hypertension and hyperlipidemia. Diabetes co-existing with hypertension and hyperlipidemia were not shown to be risk factors for the onset of dry AMD.


Sujet(s)
Diabète , Hyperlipidémies , Hypertension artérielle , Dégénérescence maculaire , Études transversales , Diabète/épidémiologie , Humains , Hyperlipidémies/complications , Hyperlipidémies/épidémiologie , Hypertension artérielle/complications , Hypertension artérielle/épidémiologie , Dégénérescence maculaire/épidémiologie , Dégénérescence maculaire/étiologie , Facteurs de risque
2.
Gene ; 717: 143987, 2019 Oct 30.
Article de Anglais | MEDLINE | ID: mdl-31362037

RÉSUMÉ

To improve the accuracy and genetic progress of blue fox breeding, the relationships between genetic polymorphisms and growth and reproductive traits of the blue fox were investigated. MC4R, MC3R, INHA and INHBA were selected as candidate genes for molecular evolution and statistical analyses. Single-factor variance analyses showed that the MC4R (g.267C > T, g.423C > T, and g.731C > A) and MC3R (g.677C > T) genotypes had significant impacts on body weight, chest circumference, abdominal perimeter and body mass index (BMI) (P < 0.05) in blue fox. The MC4R and MC3R combined genotypes had significant effects on the body weight and abdominal circumference. The different genotypes of INHA g.75G > A had significant effects on female fecundity, whereas the different genotypes of INHBA g.404G > T and g.467G > T and the INHA and INHBA combined genotypes had significant effects on male fecundity. The proteins encoded by the open reading frames (ORFs) of different polymorphic loci were predicted and analysed. The aims of this study were to identify genetic markers related to growth and reproduction in the blue fox and to provide an efficient, economical and accurate theoretical approach for auxiliary fox breeding.


Sujet(s)
Renards/croissance et développement , Renards/génétique , Polymorphisme de nucléotide simple , Reproduction/génétique , Animaux , Mensurations corporelles/génétique , Poids/génétique , Chine , Évolution moléculaire , Femelle , Renards/physiologie , Marqueurs génétiques , Sous-unités bêta de l'inhibine/composition chimique , Sous-unités bêta de l'inhibine/génétique , Inhibines/composition chimique , Inhibines/génétique , Déséquilibre de liaison , Mâle , Mutation , Récepteur de la mélanocortine de type 3/composition chimique , Récepteur de la mélanocortine de type 3/génétique , Récepteur de la mélanocortine de type 4/composition chimique , Récepteur de la mélanocortine de type 4/génétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE